Skip to main content
Journal cover image

Programmed death ligand 1 (PD-L1) as an immunotherapy target in patients with glioblastoma.

Publication ,  Journal Article
Vlahovic, G; Fecci, PE; Reardon, D; Sampson, JH
Published in: Neuro Oncol
August 2015

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Neuro Oncol

DOI

EISSN

1523-5866

Publication Date

August 2015

Volume

17

Issue

8

Start / End Page

1043 / 1045

Location

England

Related Subject Headings

  • Oncology & Carcinogenesis
  • Lymphocytes, Tumor-Infiltrating
  • Humans
  • Glioblastoma
  • Brain Neoplasms
  • B7-H1 Antigen
  • 3211 Oncology and carcinogenesis
  • 1112 Oncology and Carcinogenesis
  • 1109 Neurosciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Vlahovic, G., Fecci, P. E., Reardon, D., & Sampson, J. H. (2015). Programmed death ligand 1 (PD-L1) as an immunotherapy target in patients with glioblastoma. Neuro Oncol, 17(8), 1043–1045. https://doi.org/10.1093/neuonc/nov071
Vlahovic, Gordana, Peter E. Fecci, David Reardon, and John H. Sampson. “Programmed death ligand 1 (PD-L1) as an immunotherapy target in patients with glioblastoma.Neuro Oncol 17, no. 8 (August 2015): 1043–45. https://doi.org/10.1093/neuonc/nov071.
Vlahovic G, Fecci PE, Reardon D, Sampson JH. Programmed death ligand 1 (PD-L1) as an immunotherapy target in patients with glioblastoma. Neuro Oncol. 2015 Aug;17(8):1043–5.
Vlahovic, Gordana, et al. “Programmed death ligand 1 (PD-L1) as an immunotherapy target in patients with glioblastoma.Neuro Oncol, vol. 17, no. 8, Aug. 2015, pp. 1043–45. Pubmed, doi:10.1093/neuonc/nov071.
Vlahovic G, Fecci PE, Reardon D, Sampson JH. Programmed death ligand 1 (PD-L1) as an immunotherapy target in patients with glioblastoma. Neuro Oncol. 2015 Aug;17(8):1043–1045.
Journal cover image

Published In

Neuro Oncol

DOI

EISSN

1523-5866

Publication Date

August 2015

Volume

17

Issue

8

Start / End Page

1043 / 1045

Location

England

Related Subject Headings

  • Oncology & Carcinogenesis
  • Lymphocytes, Tumor-Infiltrating
  • Humans
  • Glioblastoma
  • Brain Neoplasms
  • B7-H1 Antigen
  • 3211 Oncology and carcinogenesis
  • 1112 Oncology and Carcinogenesis
  • 1109 Neurosciences